Getting diagnosed with breast cancer is a lot to handle. Triple Negative Breast Cancer (TNBC) is a type of breast cancer that is diagnosed in two U.S. women every hour, adding up to over 17,000 U.S. women per year. TNBC develops in the breast because of the presence of abnormal or cancer cells that look and behave differently from the normal cells in the breast. TNBC is “triple negative” because these cancer cells lack three types of proteins that are known to help other cancer cells grow. These proteins are called receptors, and they are usually located on the surface of or inside of cells: estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth fact receptor 2 (HER2). There are several drugs that are targeted to block ER, PR and HER2 so that the cancer cells won’t grow. Since TNBC cells do not have any of the receptors, these types of treatment do not work. However, if caught early, TNBC can often be treated successfully with the common treatments of chemotherapy, radiation and/or surgery.
You have some important decisions to make! Learning that you have triple negative breast cancer (TNBC) adds an additional layer of questions about your treatment plan and survivorship. Our TNBC Guidebook will help you understand what TNBC is; risk factors; treatment options; and empower you to use your voice to engage your healthcare team.
Visit https://www.tigerlilyfoundation.org/breast-cancer-toolkit/educational-guidebooks/ to download and read our guidebook today!